Skip to main content

Advertisement

Figure 1 | Cancer Cell International

Figure 1

From: Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells

Figure 1

Effects of tunicamycin (TM) on protein synthesis (A) and glycoprotein synthesis (B) in UWOV2 ovarian carcinoma cells in culture. Protein synthesis was monitored by measuring the incorporation of [35S]methionine into cellular protein at various time intervals in the absence (control) or presence (TM-treated) of the antibiotic. Glycoprotein synthesis as a function of TM concentration was evaluated by determining the amount of [3H]glucosamine incorporated into cellular protein after 16h of exposure to the antibiotic. Data represent means ± SEM (n = 4). Two-tailed p values for the difference between control and TM-treated cells are presented within bars.

Back to article page